Free Shipping on Orders of $50 or more.

Asthma therapeutic development by theophylline complex in nano-scale - Paperback

Asthma therapeutic development by theophylline complex in nano-scale - Paperback

Regular price $93.15
Sale price $93.15 Regular price
Sale Sold out
Unit price
/per 
This is a pre order item. We will ship it when it comes in stock.
Lock Secure Transaction

by Zainab Sabri Abbas (Author)

Asthma is one of the most common inflammatory disorders in all ages and cultures. Asthma affects all people. It is a chronic disease caused by airway blockage in the lungs. Characteristics of asthma include wheezing, tightness of the chest, and respiratory problems. Clinical signs and symptoms are used to diagnose asthma. In asthma patients with asthma, phosphodiesterase PDEs typically split off phosphorous groups and decrease cyclic Adenosine monophosphate cAMP or cyclic guanosine monophosphate cGMP in target cells. The amount of serum PDE increases in the cyclic extracellular nucleotides. ln this book, we review A novel synthesis-therapy in nanoscale for asthma patients by inhibits phosphodiesterase enzyme.

Number of Pages: 120
Dimensions: 0.28 x 9 x 6 IN
Publication Date: March 23, 2021